Research Article| Volume 25, ISSUE 6, P1431-1443, June 2016

Type 2 Diabetes and Hemorrhagic Stroke: A Population-Based Study in Spain from 2003 to 2012


      The objective of this study is to compare trends in outcomes for intracerebral hemorrhagic stroke in people with or without type 2 diabetes in Spain between 2003 and 2012.


      We selected all patients hospitalized for hemorrhagic stroke using national hospital discharge data. We evaluated annual incident rates stratified by diabetes status. We analyzed trends in the use of diagnostic and therapeutic procedures, patient comorbidities, in-hospital mortality (IHM), length of hospital stay, and readmission rate in 1 month.


      We identified a total of 173,979 discharges of patients admitted with hemorrhagic stroke (19.1% with diabetes). Incidences were higher among those with than those without diabetes in all the years studied. Diabetes was positively associated with stroke (incidence rate ratio [IRR] = 1.38, 95% confidence interval [CI] 1.35-1.40 for men; IRR = 1.31, 95% CI 1.29-1.34 for women). Length of stay decreased significantly and readmission rate remained stable for both groups (around 5%). We observed a significant increase in the use of decompressive craniectomy from 2002 to 2013. Mortality was positively associated with older age, with higher comorbidity and atrial fibrillation as risk factors. We found a negative association with the use of decompressive craniectomy. Mortality did not change over time among diabetic men and women. In those without diabetes, mortality decreased significantly over time. Suffering diabetes was not associated with higher mortality.


      Type 2 diabetes is associated with higher incidence of hemorrhagic stroke but not with IHM. Incidence among diabetic people remained stable over time. In both groups, the use of decompressive craniectomy has increased and is associated with a decreased mortality.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bejot Y.
        • Benatru I.
        • Rouaud O.
        • et al.
        Epidemiology of stroke in Europe: geographic and environmental differences.
        J Neurol Sci. 2007; 262: 85-88
        • Warlow C.
        • Sudlow C.
        • Dennis M.
        • et al.
        Lancet. 2003; 362: 1211-1224
        • Grysiewicz R.A.
        • Thomas K.
        • Pandey D.K.
        Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors.
        Neurol Clin. 2008; : 871-895
        • Instituto Nacional de Estadística
        Defunciones según la causa de muerte.
        (Available at:) (Accessed March 11, 2015)
        • Marrugat J.
        • Arboix A.
        • García-Eroles L.
        • et al.
        [The estimated incidence and case fatality rate of ischemic and hemorrhagic cerebrovascular disease in 2002 in Catalonia].
        Rev Esp Cardiol. 2007; 60: 573-580
        • Brea A.
        • Laclaustra M.
        • Martorell E.
        • et al.
        [Epidemiology of cerebrovascular disease in Spain].
        Clin Invest Arterioscl. 2013; 25: 211-217
        • Díaz-Guzman J.
        • Egido-Herrero J.A.
        • Gabriel-Sanchez R.
        • et al.
        [Incidence of strokes in Spain. Methodological foundations of the IBERICTUS study].
        Rev Neurol. 2008; 47: 617-623
        • Vega T.
        • Zurriaga O.
        • Ramos J.M.
        • et al.
        Stroke in Spain: epidemiologic incidence and patterns: a health sentinel network study.
        J Stroke Cerebrovasc Dis. 2009; 18: 11-16
        • Díaz-Guzmán J.
        • Egido J.A.
        • Gabriel-Sánchez R.
        • et al.
        Stroke and transient ischemic attack incidence rate in Spain: the IBERICTUS Study.
        Cerebrovasc Dis. 2012; 34: 272-281
        • Feigin V.L.
        • Lawes C.M.
        • Bennett D.A.
        • et al.
        Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review.
        Lancet Neurol. 2009; 8: 355-369
        • Idris I.
        • Thomson G.A.
        • Sharma J.C.
        Diabetes mellitus and stroke.
        Int J Clin Pract. 2006; 60: 48-56
        • Banerjee C.
        • Moon Y.P.
        • Paik M.C.
        • et al.
        Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study.
        Stroke. 2012; 43: 1212-1217
        • Eriksson M.
        • Carlberg B.
        • Eliasson M.
        The disparity in long-term survival after a first stroke in patients with and without diabetes persists: the Northern Sweden MONICA study.
        Cerebrovasc Dis. 2012; 34: 153-160
        • Sarwar N.
        • Gao P.
        • et al.
        • Emerging Risk Factors Collaboration
        Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.
        Lancet. 2010; 375: 2215-2222
        • Shah A.D.
        • Langenberg C.
        • Rapsomaniki E.
        • et al.
        Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1 ⋅ 9 million people.
        Lancet Diabetes Endocrinol. 2015; 3: 105-113
        • American Diabetes Association
        Standards of medical care in diabetes-2013.
        Diabetes Care. 2013; 36: S11-S66
        • Nwaneri C.
        • Cooper H.
        • Bowen-Jones D.
        Mortality in type 2 diabetes mellitus. Magnitude of the evidence from a systematic review and meta-analysis.
        Br J Diabetes Vasc Dis. 2013; 13: 192-207
        • Instituto Nacional de Gestión Sanitaria, Ministerio de Sanidad, Servicios Sociales e Igualdad
        Conjunto Mínimo Básico de Datos, Hospitales del INSALUD.
        (Available at:) (Accessed March 11, 2015)
        • Ministerio de Sanidad, Servicios Sociales e Igualdad
        Encuesta Nacional de Salud de España.
        (Available at:) (Accessed March 11, 2015)
        • Soriguer F.
        • Goday A.
        • Bosch-Comas A.
        • et al.
        Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the [email protected] Study.
        Diabetologia. 2012; 55: 88-93
        • Instituto Nacional de Estadística
        Population estimates.
        (Available at:) (Accessed March 11, 2015)
        • Charlson M.E.
        • Pompei P.
        • Ales K.L.
        • et al.
        A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
        J Chronic Dis. 1987; 40: 373-383
        • Thomsen R.W.
        • Nielsen J.S.
        • Ulrichsen S.P.
        • et al.
        The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) study: collection of baseline data from the first 580 patients.
        Clin Epidemiol. 2012; 4: 43-48
        • Vasiliadis A.V.
        • Zikic M.
        Current status of stroke epidemiology in Greece: a panorama.
        Neurol Neurochir Pol. 2014; 48: 449-457
        • Jimenez Caballero P.E.
        • Lopez Espuela F.
        • Portilla Cuenca J.C.
        • et al.
        Charlson comorbidity index in ischemic stroke and intracerebral hemorrhage as predictor of mortality and functional outcome after 6 months.
        J Stroke Cerebrovasc Dis. 2013; 22: 214-218
        • Hu G.
        • Jousilahti P.
        • Barengo N.C.
        • et al.
        Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes.
        Diabetes Care. 2005; 28: 799-805
        • Bangalore S.
        • Kumar S.
        • Lobach I.
        • et al.
        Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and Bayesian random effects meta-analyses of randomized trials.
        Circulation. 2011; 123: 2799-27810
        • Marini C.
        • Carolei A.
        Epidemiology of stroke in the young.
        Stroke. 2003; 34: e13
        • Nichols G.A.
        • Reinier K.
        • Chugh S.S.
        Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation.
        Diabetes Care. 2009; 32: 1851-1856
        • Huxley R.R.
        • Filion K.B.
        • Konety S.
        • et al.
        Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation.
        Am J Cardiol. 2011; 108: 56-62
        • Marfella R.
        • Rizzo M.R.
        • Capoluongo M.
        • et al.
        Cryptogenic stroke and diabetes: a probable link between silent atrial fibrillation episodes and cerebrovascular disease.
        Expert Rev Cardiovasc Ther. 2014; 12: 323-329
        • Lip G.Y.
        • Nieuwlaat R.
        • Pisters R.
        • et al.
        Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation.
        Chest. 2010; 137: 263-272
        • Lane D.A.
        • Lip G.Y.
        Use of the CHA2DS2-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation.
        Circulation. 2012; 126: 860-865
        • Garcia J.T.
        • Robles L.R.
        Epidemiology of stroke in patients with diabetes.
        Av Diabetol. 2010; 26: 397-402
        • Hu G.
        • Sarti C.
        • Jousilahti P.
        • et al.
        The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality.
        Stroke. 2005; 36: 2538-2543
        • Ergul A.
        • Abdelsaid M.
        • Fouda A.Y.
        • et al.
        Cerebral neovascularization in diabetes: implications for stroke recovery and beyond.
        J Cereb Blood Flow Metab. 2014; 34: 553-563
        • Peters S.A.
        • Huxley R.R.
        • Woodward M.
        Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775, 385 individuals and 12,539 strokes.
        Lancet. 2014; 383: 1973-1980
        • Megherbi S.E.
        • Milan C.
        • Minier D.
        • et al.
        Association between diabetes and stroke subtype on survival and functional outcome 3 month after stroke: data from the European BIOMED Stroke Project.
        Stroke. 2003; 34: 688-694
        • Arboix A.
        • Massons J.
        • García-Eroles L.
        • et al.
        Diabetes is an independent risk factor for in-hospital mortality from acute spontaneous intracerebral hemorrhage.
        Diabetes Care. 2000; 23: 1527-1532
        • Lopez-de-Andres A.
        • Jimenez-García R.
        • Hernandez-Barrera V.
        • et al.
        National trends in utilization and outcomes of coronary revascularization procedures among people with and without type 2 diabetes in Spain (2001-2011).
        Cardiovasc Diabetol. 2014; 13: 3
        • Lu C.J.
        • Sun Y.
        • Muo C.H.
        • et al.
        Risk of stroke with thiazolidinediones: a ten-year nationwide population-based cohort study.
        Cerebrovasc Dis. 2013; 36: 145-151
        • Fonville S.
        • Zandbergen A.A.
        • Vermeer S.E.
        • et al.
        Prevalence of prediabetes and newly diagnosed diabetes in patients with a transient ischemic attack or stroke.
        Cerebrovasc Dis. 2013; 36: 283-289